DQ molecules are the principal stimulators ofde novodonor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant
- 25 April 2014
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 27 (7) , 667-673
Abstract
Data on the different HLA-antibody (Ab) categories in pediatric kidney recipients developing de novo donor-specific Abs (DSA) after transplantation are scarce. We retrospectively evaluated 82 consecutive nonsensitized pediatric recipients of a first kidney graft for de novo HLA Ab occurrence and antigen specificity. At a median follow-up of 6 years, 29% of patients developed de novo DSA, while 45% had de novo non-DSA. DSA appeared at 25-month median time post-transplant and were mostly directed toward HLA-DQ antigens. Considering each HLA antigen, the estimated rate of DQ DSA (7.55 per 100 person-years) was much higher than the rates observed for non-DQ DSA. The HLA-DQ Ab recognized determinants of the DQβ chain in 70% of cases, α chain in 25% of cases, and both chains in one patient. Non-DSA peaked earlier than DSA, and were largely directed against HLA class I specificities that belonged to HLA-A- and HLA-B-related cross-reacting epitope groups (CREG) in 56% of cases. Our results indicate a need for evaluating HLA-DQ compatibilities in kidney allocation, in order to minimize post-transplant development of de novo DSA, known to be responsible for antibody-mediated rejection and graft loss.Keywords
Funding Information
- Regione Lombardia (E48C13000050001)
This publication has 28 references indexed in Scilit:
- Posttransplant De Novo Donor-Specific HLA Antibodies Identify Pediatric Kidney Recipients at Risk for Late Antibody-Mediated RejectionAmerican Journal of Transplantation, 2012
- Revisiting Traditional Risk Factors for Rejection and Graft Loss After Kidney TransplantationAmerican Journal of Transplantation, 2011
- Surveillance of alloantibodies after transplantation identifies the risk of chronic rejectionKidney International, 2011
- Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney TransplantationJournal of the American Society of Nephrology, 2010
- Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft FailureTransplantation, 2010
- De Novo Donor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft FailureAmerican Journal of Transplantation, 2009
- Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: The North Italy Transplant program approachHuman Immunology, 2009
- Identifying Specific Causes of Kidney Allograft LossAmerican Journal of Transplantation, 2009
- Factors Associated With and Predictive of Persistence of Donor-Specific Antibody After Treatment With Plasmapheresis and Intravenous ImmunoglobulinHuman Immunology, 2005
- Kidney graft failure and presensitization against HLA Class I and Class II antigens1Transplantation, 2002